(Q46648138)

23 December 2017

title

Angiotensin II receptor antagonism reverts the selective cardiac BNP upregulation and secretion observed in myocarditis (English)

1 reference

23 December 2017

author name string

Tsuneo Ogawa

1

1 reference

23 December 2017

John P Veinot

2

1 reference

23 December 2017

Mercedes L Kuroski de Bold

3

1 reference

23 December 2017

Tina Georgalis

4

1 reference

23 December 2017

Adolfo J de Bold

5

1 reference

23 December 2017

publication date

11 April 2008

1 reference

23 December 2017

American Journal of Physiology Heart and Circulatory Physiology

published in

1 reference

23 December 2017

volume

294

1 reference

23 December 2017

issue

6

1 reference

23 December 2017

page(s)

H2596-603

1 reference

23 December 2017

Cancer patients with markedly elevated B-type natriuretic peptide may not have volume overload

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00215.2008

Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00215.2008

Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists in experimental myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00215.2008

Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00215.2008

Determinants of inducible brain natriuretic peptide promoter activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00215.2008

Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00215.2008

Rapamycin ameliorates experimental autoimmune myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00215.2008

Discoordinate modulation of natriuretic peptides during acute cardiac allograft rejection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00215.2008

Beneficial effects of olmesartan, a novel angiotensin II receptor type 1 antagonist, upon acute autoimmune myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00215.2008

Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00215.2008

Differential effects of olmesartan and ramipril on inflammatory response after myocardial infarction in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00215.2008

Relationships between plasma levels of matrix metalloproteinases and neurohormonal profile in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00215.2008

Olmesartan, a novel AT1 antagonist, suppresses cytotoxic myocardial injury in autoimmune heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00215.2008

MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00215.2008

10.1152/AJPHEART.00215.2008

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017